Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06492187 · ClinicalTrials.gov registry record
Triage Survey for Infectious Disease Eligibility
A clinical trial of HIV-1-infection and Infectious Disease, sponsored by Brooklyn Clinical Research.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT06492187 is a study of HIV-1-infection and Infectious Disease that is actively recruiting participants, run by Brooklyn Clinical Research. The registered enrollment target is 10,000 participants, above the 211-participant average among 71 other HIV-1-infection trials with a reported enrollment target (4639% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06492187, a study of HIV-1-infection and Infectious Disease, is actively recruiting participants, sponsored by Brooklyn Clinical Research.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
SWIFT-ID-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials for diagnosis, treatment, or prevention of infectious diseases such as in the areas of HIV, vaccines, and other infectious-diseases areas. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical/surgical history, physical examination, comorbidities, and any current symptoms. Informed consent will be done electronically (preferable) or on paper. Informed consent may be done in-person or remotely, depending on patient preference. Information related to HIV, hepatitis B and C, other infectious diseases, or substance use disorder will also be obtained if applicable. Site staff may collect vital signs, fingerpick testing, urine drug screens, blood draws, EKG, and pregnancy tests. Some testing may be recommended in a fasting condition. A doctor will review medical history and results of the above evaluations with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians, other providers, and pharmacies to determine eligibility for clinical trials. A follow-up phone call may be needed to discuss testing results and/or trial eligibility. If a participant is deemed eligible for future trials and if the participant remains interested, counseling on contraception requirements for trials will be discussed.
Conditions Studied
Study Locations (1)
New York
- Brooklyn Clinical Research - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2024-06-28 |
| Est. Completion | 2029-01-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06492187
The ClinicalTrials.gov registry entry for NCT06492187 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 211-participant average among 71 other HIV-1-infection trials with a reported enrollment target (4639% higher). The listed sponsor is Brooklyn Clinical Research, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV-1-infection appearing as the primary indexed condition, and to 0 interventions.
NCT06492187 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06492187 about?
NCT06492187 is a clinical study titled "Triage Survey for Infectious Disease Eligibility". SWIFT-ID-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials for diagnosis, treatment, or prevention of infectious diseases such as in the areas of HIV, vaccines, and other infectious-diseases areas. A physician wi...
What is the current status of trial NCT06492187?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2024-06-28. Estimated completion is 2029-01-28.
What conditions does trial NCT06492187 study?
This clinical trial studies the following conditions: HIV-1-infection, Infectious Disease, Vaccination; Infection.
Who is sponsoring clinical trial NCT06492187?
This trial is sponsored by Brooklyn Clinical Research, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06492187 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV-1-infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Coronary Vascular Health in Women
RECRUITING · Phase 2
-
Study of GS-3242 in Participants With HIV-1; Substudy-05
RECRUITING · Phase 1
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
RECRUITING
-
Ending the Epidemic Interventions in the Dental Setting - UH3
RECRUITING · NA
-
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.